NTAGI panel recommends inclusion of Covovax in vaccination drive for 12-17 age group
The Standing Technical Sub-Committee of the NTAGI has recommended inclusion of the Serum Institute’s Covovax in the national COVID-19 vaccination programme for children aged 12 to 17 years, sources said…